Whole-parasite malaria vaccine shows promise in clinical trial; Vaccine is first of its kind to earn FDA approval to test in humans

For the first time, a malaria vaccine that uses the entire parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study. The vaccine is unique in that it employs the entire malaria parasite. Researchers found that the vaccine could provide unprecedented immune responses when administered intravenously.

Read the whole article on Science Daily

More from Science Daily